Division News

Victoria Seewaldt, MD, professor of medicine (Medical Oncology) and director of the Breast Cancer Prevention Program at the Women’s Wellness Clinic, learned recently that  she and her colleagues at Duke, along with

This week, the Department of Medicine is beginning a search for a new chief of the Division of Medical Oncology.

Tom LeBlanc, MD, MA, current fellow in both hospice and palliative medicine and medical oncology and former chief resident, learned this month that he's been chosen as a 2012 Research Scholar by the American Academy of Hospice and Palliative Medicine (AAHPM). The AAHPM chooses just 6 fellows/jun

Arif H.

Gary Lyman, MD, MPH, professor of medicine (Medical Oncology) is News & Observer Tar Heel of the Week. This article profiles Dr. Lyman and his recent research into cancer treatments.

Victoria Seewaldt, MD, professor of medicine (Medical Oncology) and director of the Breast Cancer Prevention Program at the Women’s Wellness Clinic, received a National Institutes of Health R01 grant for a study called Targeted Chemoprevention of Breast Cancer: From the Bench to Clinical Testing. The grant, which has grown out of collaboration between Duke University and CAARE Inc., a Durham-based nonprofit that provides healthcare to l

The joint Pediatric and Medicine Fellows’ Research and Career Development Conference will be held today, Tuesday, March 20, in the Searle Center Lecture Room from 4-5:30 pm. Presentations will be: Pediatric Fellow Research in Progress “Oral Tolerance and the Enteric Microbiome" Laurie McWilliams, MD (Allergy/Immunology) Medicine Fellow Research in Progress “Crossing the Quality-Outcomes Chasm in Oncology through Data-driven Evidence Development” Arif Kamal, MD (Oncology) Career Development Topic “Opportunistic Approach to Health Services F

The joint Pediatric and Medicine Fellows’ Research and Career Development Conference will be held today, Tuesday, Feb.

Medicine Grand Rounds on Fri., Feb. 17 at 8am in Duke Hospital room 2002 will feature Richard Riedel, MD, assistant professor of medicine (Medical Oncology) and associate director of the Duke Sarcoma Program. Dr.

Gary Lyman, MD, MPH, professor of medicine (Medical Oncology), on camera at the San Antonio Breast Cancer Symposium in December talking about the BOLERO-2 trial as a potentially practice-changing development in the field of breast cancer. He added that more agents are needed for the treatment of advanced metastatic disease.